Login / Signup

Difamilast, a selective phosphodiesterase 4 inhibitor, ointment in paediatric patients with atopic dermatitis: a phase III randomized double-blind, vehicle-controlled trial.

H SaekiN BabaK ItoD YokotaHidetsugu Tsubouchi
Published in: The British journal of dermatology (2021)
Difamilast 0·3% and 1% ointments are superior to vehicle and well tolerated in Japanese paediatric patients with AD.
Keyphrases
  • phase iii
  • double blind
  • placebo controlled
  • open label
  • atopic dermatitis
  • clinical trial
  • intensive care unit
  • phase ii
  • emergency department
  • study protocol
  • randomized controlled trial